UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012059
Receipt number R000013944
Scientific Title Evaluation of effect of Propolis on CO2 output, urine pH and insulin resistance
Date of disclosure of the study information 2013/10/21
Last modified on 2015/04/17 15:12:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of effect of Propolis on CO2 output, urine pH and insulin resistance

Acronym

Propolis, CO2 output, urine pH and insulin resistance

Scientific Title

Evaluation of effect of Propolis on CO2 output, urine pH and insulin resistance

Scientific Title:Acronym

Propolis, CO2 output, urine pH and insulin resistance

Region

Japan


Condition

Condition

type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to examine the effects of Propolis for acid output and insulin resistance in patients with type 2 diabetes

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

CO2 output, urine pH, HOMA-IR

Key secondary outcomes

fasting plasma glucose, HbA1c, serum insulin, blood ketone body, total cholesterol, HDL. LDL, triglyceride, remnant lile particle cholesterol(RLP-C), uric acid


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Brazilian Propolis(450.0mg/day)

Interventions/Control_2

placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

35 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1) Patients who are able to give written informed consent
2) Age is over 35 years and less than 75 years
3) Type of practice: outpatient department
4) Patients are able to do the following things in this trial - getting good compliance with consuming investigational food and coming to hospital

Key exclusion criteria

1) Patients who did not agree with this study
2)Patients with severe renal dysfunction and severe hepatic dysfunction
3)Pregnant women, women who may be pregnant, and breast-feeding women
4)Patients treated with insulin
5)Patients judged by the investigator to be ineligible for some other reason

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Michiaki Fukui

Organization

Kyoto Prefectural University of Medicine, Graduate School of Medical Science

Division name

Department of Endocrinology and Metabolism

Zip code


Address

465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566 Japan

TEL

+81-75-251-5505

Email

sayarinapm@hotmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Takuya Fukuda

Organization

Kyoto Prefectural University of Medicine, Graduate School of Medical Science

Division name

Department of Endocrinology and Metabolism

Zip code


Address

465 Kajii-cho, Kamigyo-ku, Kyoto, 602-8566 Japan

TEL

+81-75-251-5506

Homepage URL


Email

fukudatakuya0720@gmail.com


Sponsor or person

Institute

Kyoto Prefectural University of Medicine, Graduate School of Medical Science

Institute

Department

Personal name



Funding Source

Organization

Yamada Apiculture Center Inc. (Okayama, Japan)

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 10 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 10 Month 02 Day

Date of IRB


Anticipated trial start date

2013 Year 10 Month 21 Day

Last follow-up date

2014 Year 07 Month 31 Day

Date of closure to data entry

2014 Year 08 Month 31 Day

Date trial data considered complete

2014 Year 10 Month 05 Day

Date analysis concluded

2014 Year 10 Month 05 Day


Other

Other related information



Management information

Registered date

2013 Year 10 Month 17 Day

Last modified on

2015 Year 04 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013944


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name